- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06097884
Healthy School mEAls With Less Salt:an Action to Reduce Salt Intake in School Meals for Children in Rural China (HEALS-child)
Healthy School mEAls With Less Salt:an Action to Reduce Salt Intake in School Meals for Children in Rural China(HEALS-child)
Study Overview
Status
Conditions
Detailed Description
The HEALS-Child action(Healthy School mEAls With Less Salt:an Action to Reduce Salt Intake in School Meals for Children in Rural China)is a project launched by China Development Research Foundation, aiming to reduce the salt in school meals and improve the nutrition for rural students. The goal of the study is to evaluate the effectiveness, feasibility, safety and cost-effectiveness of two salt reduction strategies: replacing usual salt with salt substitute in school meals, and replacing bowls with trays in school cafeteria. The study has two parts: the main study evaluates the salt substitute intervention, and the ancillary study evaluates the tray intervention.
1. Main study:
Aims:
The aim in the main study is to test if replacing usual salt with the market available salt substitute in school meals could significantly reduce systolic blood pressure among rural school student. The corresponding null hypotheses in the main study is: the mean change from the baseline in systolic blood pressure of the students in schools that are supplied with salt substitute is equal to that in schools that are supplied with usual salt.
Study design:
In the main study, over 16000 students from around 320 elementary or junior high school in rural China will be cluster-randomized into the two groups: 1. Salt substitute 2.usual salt. The salt substitute (NaCl 75% and KCl 25%) will be centrally provided. The intervention will last for two semesters(around 10-months).
Before starting the intervention, 50 students were randomly selected from each school, and blood pressure, spot urine sodium and potassium and other indicators were measured at baseline.
The randomization will be conducted centrally by the study coordinating center at Peking University Clinical Research Institute, after the baseline survey completed.
The students will be followed up for blood pressure measurements and urine collection at the end of the first and second semesters after the intervention.
Outcomes:
The primary outcome in the main study is the change in systolic blood pressure from baseline to follow-up. The secondary outcomes in the main study includes: The incidence of hypertension, the change in DBP, spot urine potassium, spot urine sodium, incremental cost-effectiveness ratio (ICER).
Power analysis and statistical analysis:
On the assumptions of an intraclass correlation of 0.02, the number of clusters of 320 and 50 students in each school, and an α value of 0.05, the study to detect a mean 0.8 mmHg reduction in systolic blood pressure (SD, 10 mm Hg) between the intervention groups would have a power of 94.8%.
Linear models adjusted for clustering based on participants with available measures were used to assess continuous outcomes. Generalized linear mixed model were used for analysis of effects on categorical outcomes.
- Ethical considerations:
The study will be submitted to and approved by the Peking University IRB, which has the full accreditation from AAHRRP. The study salt substitute is the product available on Chinese market and has been approved manufactured according to the product standards issued by the ministry of health.
2. Ancillary study:
Aims:
The aim in the ancillary study is to test if replacing bowls with trays in school cafeteria could significantly reduce spot urine sodium among rural school student. The corresponding null hypotheses in the ancillary study is: the mean change from the baseline in spot urine sodium of the students in schools that are supplied with meal trays is equal to that in schools that using bowls.
Study design:
In the ancillary study, around 500 students from 10 elementary or junior high school in rural China will be cluster-randomized into the two groups: 1. meal trays 2.bowls. The meal trays will be centrally provided. The intervention will last for two semesters (around 10-months).
Before starting the intervention, 50 students were randomly selected from each school, spot urine sodium and other indicators were measured at baseline.
The randomization will be conducted centrally by the study coordinating center at Peking University Clinical Research Institute, after the baseline survey completed.
The students will be followed up for urine collection at the end of the first and second semesters after the intervention.
Outcomes:
The primary outcome in the ancillary study is the change in spot urine sodium from baseline to follow-up. The secondary outcomes in the ancillary study includes incremental cost-effectiveness ratio (ICER).
Power analysis and statistical analysis:
On the assumptions of an intraclass correlation of 0.02, the number of clusters of 10 and 50 students in each school, and an α value of 0.05, the study to detect a mean 1g reduction in spot urine sodium (SD, 2.15g) between the intervention groups would have a power of 90.0%.
Linear models adjusted for clustering based on participants with available measures were used to assess continuous outcomes.
- Ethical considerations:
The study will be submitted to and approved by the Peking University IRB, which has the full accreditation from AAHRRP.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yifang Yuan, MD
- Phone Number: +8617310387323
- Email: yyfjulie@163.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion criteria:
Attend school stably in this academic year, and expect to take no more than one month of leave for the whole academic year; Have lunch at school at least three times a week.
Exclusion criteria:
Unable to complete the baseline blood pressure measurement and spot urine collection.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Main study intervention- Salt substitute
Replacing usual salt with salt substitute in school meals
|
replacing regular salt with salt substitute in school meals
|
Placebo Comparator: Main study control- Usual salt
Using usual salt in school meals
|
Use usual salt in school meals
|
Experimental: Ancillary study intervention- Meal tray
Replacing bowls with trays in school cafeteria
|
Replacing bowls with trays in school cafeteria
|
Placebo Comparator: Ancillary study control- Bowl
Using bowls in school cafeteria
|
Use bowls in school cafeteria
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Primary outcome for the main study-Systolic blood pressure
Time Frame: 10-month
|
The change in systolic blood pressure from baseline to follow-up
|
10-month
|
Primary outcome for the ancillary study-Spot urinary sodium
Time Frame: 10-month
|
The change in spot urinary sodium from baseline to follow-up
|
10-month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Secondary outcome for the main study-Incidence of hypertension
Time Frame: 10-month
|
The new-onset hypertension during study period
|
10-month
|
Secondary outcome for the main study-Spot urinary sodium
Time Frame: 10-month
|
The change in spot urinary sodium from baseline to follow-up
|
10-month
|
Secondary outcome for the main study-Spot urinary potassium
Time Frame: 10-month
|
The change in spot urinary potassium from baseline to follow-up
|
10-month
|
Secondary outcome for the main study-Diastolic blood pressure
Time Frame: 10-month
|
The change in diastolic blood pressure from baseline to follow-up
|
10-month
|
Secondary outcome for the main study-ICER
Time Frame: 10-month
|
Incremental cost-effectiveness ratio, defined by the difference in the cost for every unit of gain in the pertained effectiveness outcome
|
10-month
|
Secondary outcome for the ancillary study-ICER
Time Frame: 10-month
|
Incremental cost-effectiveness ratio, defined by the difference in the cost for every unit of gain in the pertained effectiveness outcome
|
10-month
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Yangfeng Wu, PhD, Peking University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2023157
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Pressure
-
DongGuk UniversityActive, not recruitingHypertension | Blood Pressure | Ambulatory Blood Pressure | Home Blood Pressure MeasurementKorea, Republic of
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
University of JordanCompletedBlood Pressure | Heart Rate | Airway PressureJordan
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
Istituto Auxologico ItalianoRecruitingArterial Hypertension | Ambulatory Blood Pressure Monitoring | Blood Pressure Determination | Home Blood Pressure MonitoringItaly
-
Swansea UniversityNational Taiwan Normal UniversityRecruitingBlood PressureTaiwan, United Kingdom
-
Columbia UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingBlood PressureUnited States
-
Yale UniversityPatient-Centered Outcomes Research InstituteRecruiting
-
University College, LondonNot yet recruiting
-
GE HealthcareRecruiting
Clinical Trials on Main study intervention-Salt substitute
-
Universidad Peruana Cayetano HerediaJohns Hopkins UniversityCompletedHypertension | Blood PressurePeru
-
Estudios Clínicos Latino AméricaPopulation Health Research InstituteRecruiting
-
Beijing Jishuitan HospitalPeking University; The George Institute for Global Health, Australia; The George... and other collaboratorsUnknown
-
NYU Langone HealthNot yet recruitingEnd Stage Kidney DiseaseUnited States
-
Royal College of Surgeons, IrelandUniversity of Dublin, Trinity College; Health Service Executive, IrelandCompletedMultimorbidity | PolypharmacyIreland
-
The George InstituteUniversity of Auckland, New Zealand; James Cook University, Queensland, Australia and other collaboratorsCompleted
-
Stanford UniversityBRAC University; Stanford King Center for Global DevelopmentRecruitingHypertension | Blood PressureBangladesh
-
The George InstitutePeking University; China Medical University, China; Northwestern University; Imperial... and other collaboratorsCompleted
-
Grand Valley State UniversityUniversity of Oklahoma; National Institute on Aging (NIA); Michigan State University and other collaboratorsCompleted
-
Institut Claudius RegaudArtios Pharma LtdRecruiting